SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2024

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

1) On May 9, 2024 the Company collected approximately $1.1 million from sales to Pfizer and on May 8, 2024 the Company collected approximately $2.6 million from sales to Brazil.

2) On April 1, 2024, the Company granted, with the approval of the Company’s compensation committee, 263,960 shares of fully-vested restricted Common Stock, in the aggregate, to its President and Chief Executive Officer under the Plan. The Company estimated the fair value of the restricted stock on the date of grant to be approximately $0.3 million.